Seema Shah Selected Research

Seema Shah Research Topics

Disease

12	Tuberous Sclerosis (Bourneville's Disease) 01/2021 - 01/2019
4	Infections 04/2022 - 08/2005
3	COVID-19 05/2022 - 01/2021
3	Epilepsy (Aura) 01/2021 - 01/2019
3	Neoplasms (Cancer) 01/2021 - 08/2015
3	Angiomyolipoma 01/2020 - 01/2019
3	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 01/2019
2	Infantile Spasms (West Syndrome) 01/2021 - 03/2019
2	Seizures (Absence Seizure) 01/2021 - 03/2019
2	Pain (Aches) 01/2021 - 02/2012
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2018 - 08/2015
2	Breast Neoplasms (Breast Cancer) 08/2015 - 03/2013
1	Disease Progression 05/2022
1	Autoimmune Diseases (Autoimmune Disease) 07/2021
1	Immune System Diseases (Immune Disorders) 07/2021
1	Chilblains (Chilblain) 01/2021
1	Headache (Headaches) 01/2021
1	Neurologic Manifestations (Neurological Manifestations) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Abdominal Pain (Pain, Abdominal) 01/2021
1	Rare Diseases (Rare Disease) 01/2021
1	Hypertension (High Blood Pressure) 01/2020
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 09/2017
1	Fat Necrosis 04/2016
1	Peritoneal Panniculitis (Sclerosing Mesenteritis) 04/2016
1	Carcinoma (Carcinomatosis) 08/2015
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 06/2015
1	Acute Kidney Injury (Acute Renal Failure) 08/2014
1	Horner Syndrome (Horner's Syndrome) 10/2012
1	Osteoarthritis 02/2012
1	Chronic Pain 02/2012
1	Inflammation (Inflammations) 02/2012
1	Sepsis (Septicemia) 08/2005

Drug/Important Bio-Agent (IBA)

13	trans-sodium crocetinate (crocetin)IBA 01/2021 - 01/2019
3	Pharmaceutical PreparationsIBA 01/2021 - 02/2012
2	Biomarkers (Surrogate Marker)IBA 05/2022 - 03/2013
2	RNA (Ribonucleic Acid)IBA 04/2022 - 01/2022
2	WastewaterIBA 04/2022 - 01/2022
2	VaccinesIBA 01/2022 - 01/2021
1	Antinuclear AntibodiesIBA 07/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Everolimus FDA Link 01/2021
1	SteroidsIBA 01/2021
1	Vigabatrin FDA Link 01/2021
1	TOR Serine-Threonine KinasesIBA 01/2020
1	Aminobutyrates (Aminobutyric Acid)IBA 03/2019
1	gamma-Aminobutyric Acid (GABA)IBA 03/2019
1	Oncogene Proteins (Oncogene Protein)IBA 01/2019
1	lipoarabinomannan (LAM)IBA 01/2019
1	MTOR InhibitorsIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 01/2018
1	LDL CholesterolIBA 09/2017
1	Triglycerides (Triacylglycerol)IBA 09/2017
1	Blood Glucose (Blood Sugar)IBA 09/2017
1	CholesterolIBA 09/2017
1	Interleukin-6 (Interleukin 6)IBA 08/2015
1	CytokinesIBA 08/2015
1	Cystatin CIBA 08/2014
1	Lipocalin-2IBA 08/2014
1	CreatinineIBA 08/2014
1	EnzymesIBA 02/2012
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2012

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2019
1	Laparotomy 04/2016
1	Duration of Therapy 06/2015
1	Percutaneous Coronary Intervention 08/2014
1	Epidural Blood Patch 10/2012
1	Analgesia 02/2012
1	Pain Management 02/2012
1	Catheters 08/2005
1	Central Venous Catheters 08/2005